PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results
Records returned : 30.
-
Guideline Profile : NHS England responsible commissioner - (excluding HIV & Cancer cont......)
Brand names include : Myalepta, Dailiport, Prevymis, Blenrep, Jemperli, Pemazyre, Alymsys, Evrysdi, risdiplam, inrebic, fedratinib, kesimpta, ofatumumab, Velmanase alfa, crizanlizumab, Ponesimod, Fintepla, Ronapreve, Idacio, Vumerity, Libmeldy, Luxturna, Spinraza, Aspaveli, Bylvay, Hepcludex, Tegsedi, Imcivree, Livtencity, Xenpozyme; Rezurock, Cevenfacta, Ceprotin, Nexviadyme, Tezspire, Lupkynis, Oxlumo
-
Guideline Profile : NHS England responsible commissioner - (excluding HIV & Cancer)
Brand names include : ABALOPARATIDE ABATACEPT ADALIMUMAB ADEFOVIR AGALSIDASE ALBUTROPIN ALEMTUZUMAB ALGLUCOSIDASE ALIPOGENE ATIPARVOVEC ALISPORIVIR ALPHA MANNOSIDASE AMBRISENTAN AMIFAMPRIDINE AMIKACIN AMPHOTERICIN LIPOSOMAL ANABASUM ANAKINRA ANIDULAFUNGIN ANIFROLUMAB ANTILYMPHOCYTE ANTIPSEUDOMONAS AERUGINOSA ANTITHROMBIN ANTITHYMOCYTE IMMUNOGLOBULIN ARIMOCLOMOL ASFOTASE ASUNAPREVIR ATACICEPT ATALUREN AUTOLOGOUS SERUM EYE DROPS AVACOPAN AZTREONAM BARDOXOLONE BASILIXIMAB BECLABUVIR BEDAQUILINE BEGELOMAB BELATACEPT BELIMUMAB BENRALIZUMAB BEPERMINOGENE PERPLASMID BETAINE BEVACIZUMAB BIMAGRUMAB BIOTIN BLISIBIMOD BORTEZOMIB BOSENTAN BRIMAPITIDE BRINCIDOFOVIR BUROSUMAB C1 ESTERASE INHIBITORS CALCIFIDIOL CANAKINUMAB CANNABIDIOL (AS EPIDIOLEX) CAPLACIZUMAB CARGLUMIC ACID CARNITINE CASPOFUNGIN CENEGERMIN CERALIFIMOD CERLIPONASE ALFA Lumacaftor/ivacaftor, Lanadelumab, Polatuzumab vedotin, Siponimod, Iqymune, Asparaginase, Turoctocog, cinacalcet
-
Guideline Profile : NHS England responsible commissioner - Cancer (NHSE list)
Brand names include : Afinitor, Ofev, Vargatef, Zytiga, Giotrif, Zaltrap, Proleukin, Lemtrada, Inlyta, Avastin, Velcade, Bosulif, Erbitux, Xalkori, Tafinlar, Sprycel, Dacogen, Xtandi, Tarceva, Iressa, Glivec, Somatuline Autogel, Tyverb, Keytruda, Imnovid, Iclusig, Stivarga, Mabthera, Rixathon, Truxima, Jakavi, Nexafar, Sutent, Torisel, Samsca, Caprelsa, Zelboraf, Verzenios, Alecensa, Trisenox, Bavencio, Mektovi, Blincyto, Adcetris, Alunbrig, Jevtana, Cabometyx, Cometriq, Kyprolis, Zykadia, Evoltra, Vizimpro, Darzalex, Qarziba, Braftovi, Halaven, Mylotarg, Imbruvica, Zydelig, Besponsa, Yervoy, Kisplyx, Vyxeos, Atriance, Nerlynx, Zejula, Opdivo, Gazyvaro, Lynparza, Tagrisso, Ibrance, Vectibix, Oncaspar, Caelyx, Myocet, Alimta, Perjeta, Pixuvri, Xofigo, Cyramza, Kisqali, Rubraca, Fotivda, Yondelis, Mekinist, Herceptin, Herzuma, Kadcyla, Kanjinti, Ontruzant, Trazimera, Lonsurf, Venclyxto, daunorubicin, lutetium, midostaurin, nelarabine, neratinib, niraparib, nivolumab, obinutuzumab, olaparib, osimertinib, palbo
-
Ibandronic acid - Bone metastases from breast cancer
Brand names include : Bondronat
-
Anastrozole - Breast cancer - chemoprevention
Brand names include : Arimidex
-
Raloxifene hydrochloride - Breast cancer - chemoprevention
-
Tamoxifen citrate - Breast cancer - chemoprevention
-
Acitretin - Cancer
-
Ivosidenib - Cancer
-
Mistletoe extract - Cancer
Brand names include : Iscador, Eurixor, Lektinol, cefalektin, AbnobaVISCUM, Helixor,Isorel, Iscucin
-
Anastrazole - Cancer - breast
Brand names include : Arimidex
-
Exemestane - Cancer - breast
Brand names include : Aromasin
-
Fulvestrant - Cancer - breast
Brand names include : Faslodex
-
Goserelin - Cancer - breast
Brand names include : Zoladex LA
-
Letrozole - Cancer - breast
Brand names include : Femara
-
Leuprorelin acetate - Cancer - breast
Brand names include : Prostap
-
Triptorelin - Cancer - breast
Brand names include : Decapeptyl
-
Tamoxifen - Gynaecomastia
Brand names include : Soltamox
-
Tolvaptan - Hyponatraemia in cancer
Brand names include : Samsca
-
Solution for injection for radioiodine (Na131) - Interventional radiology
-
Guidelines - NHS England responsible commissioner - Cancer (NHSE list cont.....)
Brand names include : Rozlytek, Ruxience, Sarclisa, Aybintio, Zercepac, Zirabev, Ibrance, Pazenir, Vitrakvi, Poteligeo, Piqray, Daurismo, Calquence, Trecondi, Trastuzumab deruxtecan, Phesgo, Retsevmo, Selumetinib, Libtayo, Lorviqua, Tecentriq, Lumykras, Sacituzumab govitecan, Rybrevant, Amsidine, Kymriah, Yescarta, Tukysa, Tepmetko, Exkivity, Tecartus, Padcev, Minjuvi, Gavreto, Scemblix, Apealea, Brukinsa, Uxil, Kimmtrak, Welireg, Vegzelma, Onureg, Lunsumio, Orgovyx, Imfinzi, Qinlock
-
Bicalutamide - Prostate cancer
Brand names include : Casodex
-
Cyproterone acetate - Prostate cancer
Brand names include : Cyprostat
-
Degarelix - Prostate cancer
Brand names include : Firmagon
-
Enzalutamide - Prostate cancer
Brand names include : Xtandi,
-
Goserelin - Prostate cancer
Brand names include : Zoladex, Novgos
-
Leuprorelin acetate - Prostate cancer
Brand names include : Prostap, Staladex
-
Relugolix - Prostate cancer
Brand names include : Orgovyx
-
Triptorelin - Prostate cancer
Brand names include : Decapeptyl, Gonapeptyl
-
Liothyronine sodium - Thyroid cancer and Parathyroid cancer
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients